PAMA Reporting for Labs
The Protecting Access to Medicare Act of 2014 (PAMA) revised the payment methodology for clinical diagnostic laboratory tests paid under the Medicare Clinical Laboratory Fee Schedule (CLFS). Under PAMA, CMS will base 2024 clinical laboratory fee schedule payment rates on private payer rates as reported by applicable labs.
Meet Compliance Requirements with Quadax
CMS Further Delays PAMA
In December 2021, the Protecting Medicare and American Farmers from Sequester Cuts Act delayed the PAMA data reporting period from 2022 to 2023. Applicable laboratories were given an additional year to report final payment data collected during the first six months of 2019.